AKT1 and hepatocellular carcinoma: Tahtouh et al. found that BIBR1532 reduced the alpha-fetoprotein (AFP) concentration (a diagnostic marker for hepatocellular carcinoma) by inhibiting the PI3K/AKT/mTOR pathway (Tahtouh et al., 2015).